Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
642.99B
Market cap642.99B
Price-Earnings ratio
41.37
Price-Earnings ratio41.37
Dividend yield
1.94%
Dividend yield1.94%
Average volume
7.84M
Average volume7.84M
High today
$271.14
High today$271.14
Low today
$264.68
Low today$264.68
Open price
$268.35
Open price$268.35
Volume
9.68M
Volume9.68M
52 Week high
$290.25
52 Week high$290.25
52 Week low
$199.38
52 Week low$199.38

Stock Snapshot

With a market cap of 642.99B, Johnson & Johnson(JNJ) trades at $267.00. The stock has a price-to-earnings ratio of 41.37 and currently yields dividends of 1.94%.

On 2026-11-19, Johnson & Johnson(JNJ) stock traded between a low of $264.68 and a high of $271.14. Shares are currently priced at $267.00, which is +0.9% above the low and -1.5% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 9.68M, against a daily average of 7.84M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $290.25 and a 52-week low of $199.38.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $290.25 and a 52-week low of $199.38.

JNJ News

Simply Wall St 2h
Income Investors Should Know That Johnson & Johnson Goes Ex-Dividend Soon

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Johnson & Johnson ( ) is about to trade ex-dividend in...

Income Investors Should Know That Johnson & Johnson Goes Ex-Dividend Soon
TipRanks 7h
Johnson & Johnson announces first commercial installation of OTTAVA system

Johnson & Johnson announced that Memorial Hermann-Texas Medical Center in Houston, Texas will be the first hospital to install the OTTAVA Robotic Surgical Syste...

24/7 Wall St. 8h
Want Steady Dividend Income? Invest in These 3 Dividend Kings With 64 Years of Raises

It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...

Want Steady Dividend Income? Invest in These 3 Dividend Kings With 64 Years of Raises

Analyst ratings

67%

of 27 ratings
Buy
66.7%
Hold
25.9%
Sell
7.4%

More JNJ News

24/7 Wall St. 8h
Want Reliable Retirement Income? Invest in These 3 Dow Jones Passive Income Dividend Stocks

It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...

Want Reliable Retirement Income? Invest in These 3 Dow Jones Passive Income Dividend Stocks
TipRanks 8h
Johnson & Johnson submits sNDA to FDA for approval of caplyta in bipolar mania

Johnson & Johnson announced the submission of a supplemental New Drug Application to the U.S. FDA seeking the approval of caplyta for the treatment of manic or...

New York Times 9h
Mavs confident Morez Johnson Jr. can be a difference-maker, despite slow start to rookie season - The New York Times

...

Mavs confident Morez Johnson Jr. can be a difference-maker, despite slow start to rookie season - The New York Times
24/7 Wall St. 1d
Invest $25,000 in These 4 Dividend Stocks to Start Building Retirement Income

It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...

Invest $25,000 in These 4 Dividend Stocks to Start Building Retirement Income
TipRanks 2d
Johnson & Johnson price target raised to $292 from $275 at BofA

BofA raised the firm’s price target on Johnson & Johnson to $292 from $275 and keeps a Neutral rating on the shares. The company enters its December 8th Enterp...

The Motley Fool 2d
Johnson & Johnson vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?

Healthcare investors often choose between established stability and high-growth innovation. Determining whether Johnson & Johnson (JNJ -1.36%) or Vertex Pharmac...

Johnson & Johnson vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?
The Motley Fool 2d
Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in Revenue

Johnson & Johnson: Steady Upward Recent Revenue Growth Johnson & Johnson (JNJ -0.97%) primarily generates revenue by developing and selling pharmaceutical and m...

Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in Revenue

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.